Year: 2024

Aribio_Logo

AriBio Receives IND Approval from China’s NMPA for POLARIS-AD, a Phase 3 Trial for the Treatment of Early Alzheimer’s Disease

SEONGNAM-SI, South Korea--(BUSINESS WIRE)--AriBio Co., Ltd. (AriBio), a biotech company dedicated to pioneering treatments for neurodegenerative diseases, announces approval of...